ID: ALA3787030

Max Phase: Preclinical

Molecular Formula: C16H12Cl2FNO

Molecular Weight: 324.18

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(/C=C/c1cccc(Cl)c1Cl)NCc1ccc(F)cc1

Standard InChI:  InChI=1S/C16H12Cl2FNO/c17-14-3-1-2-12(16(14)18)6-9-15(21)20-10-11-4-7-13(19)8-5-11/h1-9H,10H2,(H,20,21)/b9-6+

Standard InChI Key:  QUESOTHKSVEUIB-RMKNXTFCSA-N

Associated Targets(non-human)

Lymphocyte antigen 96 41 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 324.18Molecular Weight (Monoisotopic): 323.0280AlogP: 4.46#Rotatable Bonds: 4
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.63CX LogD: 4.63
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.83Np Likeness Score: -1.45

References

1. Chen G, Zhang Y, Liu X, Fang Q, Wang Z, Fu L, Liu Z, Wang Y, Zhao Y, Li X, Liang G..  (2016)  Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury.,  59  (6): [PMID:26937738] [10.1021/acs.jmedchem.5b01574]

Source